Bausch + LombvsEli Lilly and Company

BLCO and LLY stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,428.10

Value $1.35T

-0.24%
LLY's page

Bausch + Lomb (BLCO) has a market value of $7.5B and Eli Lilly and Company (LLY) $1.35T. Over the last year, with dividends, BLCO moved +35.2% and LLY +40.1%. Dividend yield: BLCO none, LLY 0.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BLCO$7.5B

    LLY$1.35T

    LLY is 180 times BLCO

  • Revenue, 12 months

    BLCO$5.4B

    LLY$86.5B

    LLY is 16 times BLCO

  • Net income, 12 months

    BLCO-$111M

    LLY$27.6B

  • Operating margin

    BLCO7.1%

    LLY–

  • ROIC

    BLCO2.6%

    LLY35.5%

    32.9 points apart

  • P/E

    BLCO–

    LLY48.9

  • Dividend yield

    BLCO0.0%

    LLY0.4%

    0.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BLCO+34.8%

LLY+146.2%

100150200250202420252026
Returns by period
PeriodBLCOWith dividendsLLYWith dividends
1 year since November 14, 2025+35.2%Price +35.2%+40.1%Price +39.3%
3 years since November 17, 2023+34.8%+10.5% a yearPrice +34.8%+146.2%+35.0% a yearPrice +141.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BLCOBausch + LombLLYEli Lilly and Company

Valuation

BLCOLLY
Valuation
Price$21.09$1,428.10
Market value$7.5B$1.35T
Enterprise value (EV)$12.0B$1.39T
P/E–48.9
P/E, 5-year median–49.9
P/B1.233.5
EV/EBIT31.340.0
Free cash flow yield3.4%1.5%

Results and growth

BLCOLLY
Results and growth
Revenue, 12 months$5.4B$86.5B
Net income, 12 months-$111M$27.6B
Free cash flow, 12 months$252M$19.7B
Earnings per share, 12 months-$0.32$30.81
Revenue growth, year on year6.5%44.7%
Revenue growth a year, past+8.4%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

BLCOLLY
Margins and returns on capital
Gross margin–83.6%
Operating margin7.1%–
Net margin-2.1%31.9%
ROIC2.6%35.5%
ROE-1.7%88.6%

Balance sheet

BLCOLLY
Balance sheet
Cash$513M$4.9B
Total debt$5.0B$49.5B
Net debt / EBITDA5.61.2
Interest cover1.0×38.9×

Dividends and buybacks

BLCOLLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield–0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BLCO or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Bausch + Lomb or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.35T) is about 180.3 times Bausch + Lomb ($7.5B), at today's prices.

How did BLCO and LLY stock do over the last 3 years?

Since November 17, 2023, BLCO's price moved +34.8% and LLY's +141.4%. With dividends: BLCO +34.8% (+10.5% a year), LLY +146.2% (+35.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, BLCO or LLY?

The dividend yield at today's price is none for Bausch + Lomb and 0.44% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

Which has the higher profit margins, Bausch + Lomb or Eli Lilly and Company?

Over the last twelve months, the net margin was -2.1% for Bausch + Lomb and 31.9% for Eli Lilly and Company, and the operating margin 7.1% and –. Revenue was $5.4B and $86.5B.

Which is the better investment, Bausch + Lomb or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.